StockNews.com Initiates Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA)

StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 1.5 % NASDAQ VNDA opened at $6.20 on Thursday. The firm has a market cap of $356.13 million, a price-to-earnings ratio […]

Related Keywords

United States ,America ,Mihael Hristos Polymeropoulos ,Joakim Wijkstrom ,News Ratings For Vanda Pharmaceuticals Daily ,Vanda Pharmaceuticals ,Vanda Pharmaceuticals Trading ,America Corp ,Allspring Global Investments Holdings ,Vanda Pharmaceuticals Inc ,Institutional Trading Of Vanda Pharmaceuticals ,Insider Transactions At Vanda Pharmaceuticals ,Millennium Management ,Get Rating ,Hristos Polymeropoulos ,Street Corp ,Asset Management ,Global Investments Holdings ,Vanda Pharmaceuticals Daily ,Nasdaq Vnda ,Vnda ,Medical ,92165910 ,Initiated Coverage ,Stocknews Com ,